Literature DB >> 23456298

S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells.

Chae Hwa Kwon1, Hyun Jung Moon, Hye Ji Park, Jin Hwa Choi, Do Youn Park.   

Abstract

S100A8 and S100A9 (S100A8/A9) are low-molecular weight members of the S100 family of calcium-binding proteins. Recent studies have reported S100A8/A9 promote tumorigenesis. We have previously reported that S100A8/A9 is mostly expressed in stromal cells and inflammatory cells between gastric tumor cells. However, the role of environmental S100A8/A9 in gastric cancer has not been defined. We observed in the present study the effect of S100A8/A9 on migration and invasion of gastric cancer cells. S100A8/ A9 treatment increased migration and invasionat lower concentrations that did not affect cell proliferation and cell viability. S100A8/A9 caused activation of p38 mitogenactivated protein kinase (MAPK) and nuclear factor-κB (NF-κB). The phosphorylation of p38 MAPK was not affected by the NF-κB inhibitor Bay whereas activation of NF-κB was blocked by p38 MAPK inhibitor SB203580, indicating that S100A8/A9-induced NF-κB activation is mediated by phosphorylation of p38 MAPK. S100A8/A9-induced cell migration and invasion was inhibited by SB203580 and Bay, suggesting that activation of p38 MAPK and NF-κB is involved in the S100A8/A9 induced cell migration and invasion. S100A8/A9 caused an increase in matrix metalloproteinase 2 (MMP2) and MMP12 expression, which were inhibited by SB203580 and Bay. S100A8/A9-induced cell migration and invasion was inhibited by MMP2 siRNA and MMP12 siRNA, indicating that MMP2 and MMP12 is related to the S100A8/A9 induced cell migration and invasion. Taken together, these results suggest that S100A8/A9 promotes cell migration and invasion through p38 MAPKdependent NF-κB activation leading to an increase of MMP2 and MMP12 in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23456298      PMCID: PMC3887919          DOI: 10.1007/s10059-013-2269-x

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  38 in total

1.  S100A8/A9 activate key genes and pathways in colon tumor progression.

Authors:  Mie Ichikawa; Roy Williams; Ling Wang; Thomas Vogl; Geetha Srikrishna
Journal:  Mol Cancer Res       Date:  2011-01-12       Impact factor: 5.852

2.  Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.

Authors:  Chin Wee Ang; Taoufik Nedjadi; Adnan A Sheikh; Elizabeth M Tweedle; Sarah Tonack; Sailish Honap; Rosalind E Jenkins; B Kevin Park; Irmgard Schwarte-Waldhoff; Ilyas Khattak; Bahram Azadeh; Andrew Dodson; Helen Kalirai; John P Neoptolemos; Paul S Rooney; Eithne Costello
Journal:  Carcinogenesis       Date:  2010-07-09       Impact factor: 4.944

3.  SPARC is associated with gastric cancer progression and poor survival of patients.

Authors:  Zhong-Sheng Zhao; Yuan-Yu Wang; Yong-Quan Chu; Zai-Yuan Ye; Hou-Quan Tao
Journal:  Clin Cancer Res       Date:  2009-12-22       Impact factor: 12.531

Review 4.  Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.

Authors:  Roopali Roy; Jiang Yang; Marsha A Moses
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

Review 5.  S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis.

Authors:  Saeid Ghavami; Seth Chitayat; Mohammad Hashemi; Mehdi Eshraghi; Walter J Chazin; Andrew J Halayko; Claus Kerkhoff
Journal:  Eur J Pharmacol       Date:  2009-10-14       Impact factor: 4.432

6.  The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase.

Authors:  Sachie Hiratsuka; Akira Watanabe; Yoshiko Sakurai; Sachiko Akashi-Takamura; Sachie Ishibashi; Kensuke Miyake; Masabumi Shibuya; Shizuo Akira; Hiroyuki Aburatani; Yoshiro Maru
Journal:  Nat Cell Biol       Date:  2008-09-28       Impact factor: 28.824

Review 7.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

8.  S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway.

Authors:  Saeid Ghavami; Iran Rashedi; Brian M Dattilo; Mehdi Eshraghi; Walter J Chazin; Mohammad Hashemi; Sebastian Wesselborg; Claus Kerkhoff; Marek Los
Journal:  J Leukoc Biol       Date:  2008-03-13       Impact factor: 4.962

9.  Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.

Authors:  Aree Moon; Hae-Young Yong; Jae-In Song; Daniela Cukovic; Sridevi Salagrama; David Kaplan; David Putt; Hyesook Kim; Alan Dombkowski; Hyeong-Reh Choi Kim
Journal:  Mol Cancer Res       Date:  2008-10       Impact factor: 5.852

10.  RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis.

Authors:  Olga Turovskaya; Dirk Foell; Pratima Sinha; Thomas Vogl; Robbin Newlin; Jonamani Nayak; Mien Nguyen; Anna Olsson; Peter P Nawroth; Angelika Bierhaus; Nissi Varki; Mitchell Kronenberg; Hudson H Freeze; Geetha Srikrishna
Journal:  Carcinogenesis       Date:  2008-08-09       Impact factor: 4.944

View more
  46 in total

1.  Activation of proMMP-2 by U46619 occurs via involvement of p(38)MAPK-NFκB-MT1MMP signaling pathway in pulmonary artery smooth muscle cells.

Authors:  Animesh Chowdhury; Soumitra Roy; Tapati Chakraborti; Kuntal Dey; Sajal Chakraborti
Journal:  Mol Cell Biochem       Date:  2013-09-25       Impact factor: 3.396

2.  Cross-talk between NADPH oxidase-PKCα-p(38)MAPK and NF-κB-MT1MMP in activating proMMP-2 by ET-1 in pulmonary artery smooth muscle cells.

Authors:  Jaganmay Sarkar; Animesh Chowdhury; Tapati Chakraborti; Sajal Chakraborti
Journal:  Mol Cell Biochem       Date:  2016-02-24       Impact factor: 3.396

3.  Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera.

Authors:  Crystal N Ellis; Regina C LaRocque; Taher Uddin; Bryan Krastins; Leslie M Mayo-Smith; David Sarracino; Elinor K Karlsson; Atiqur Rahman; Tahmina Shirin; Taufiqur R Bhuiyan; Fahima Chowdhury; Ashraful Islam Khan; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri; Jason B Harris
Journal:  Infect Immun       Date:  2015-01-05       Impact factor: 3.441

4.  Potential role of S100A8 in skin rejuvenation with the 1064-nm Q-switched Nd:YAG laser.

Authors:  Yan Qin; Xiaofeng Qin; Peng Xu; Yuanting Zhi; Weili Xia; Yongyan Dang; Jun Gu; Xiyun Ye
Journal:  Lasers Med Sci       Date:  2017-12-21       Impact factor: 3.161

5.  Establishment of S100A8 Transgenic Rats to Understand Innate Property of S100A8 and Its Immunological Role.

Authors:  Kohki Okada; Hiroshi Itoh; Yasuhiko Kamikubo; Souichi Adachi; Masaki Ikemoto
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

6.  S100A14, a mediator of epithelial-mesenchymal transition, regulates proliferation, migration and invasion of human cervical cancer cells.

Authors:  Xiangyu Wang; Jing Yang; Jingfeng Qian; Zhihua Liu; Hongyan Chen; Zhumei Cui
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

7.  Effects of silencing S100A8 and S100A9 with small interfering RNA on the migration of CNE1 nasopharyngeal carcinoma cells.

Authors:  Lin-Lin Yan; Yuan-Jiao Huang; Xiang Yi; Xue-Min Yan; Yan Cai; Qin He; Zi-Jian Han
Journal:  Oncol Lett       Date:  2015-03-31       Impact factor: 2.967

8.  Protein S100-A8: A potential metastasis-associated protein for breast cancer determined via iTRAQ quantitative proteomic and clinicopathological analysis.

Authors:  Jing-Min Zhong; Jing Li; An-Ding Kang; San-Qian Huang; Wen-Bin Liu; Yun Zhang; Zhi-Hong Liu; Liang Zeng
Journal:  Oncol Lett       Date:  2018-02-06       Impact factor: 2.967

9.  Numblike regulates proliferation, apoptosis, and invasion of lung cancer cell.

Authors:  Li Yingjie; Tang Jian; Yu Changhai; Li Jingbo
Journal:  Tumour Biol       Date:  2013-05-17

10.  Evaluation and screening of mRNA S100A genes as serological biomarkers in different stages of bladder cancer in Egypt.

Authors:  Manal F Ismail; Noha A El Boghdady; Marwa I Shabayek; Heba A Awida; Hamdy Abozeed
Journal:  Tumour Biol       Date:  2015-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.